What amount sold does AFR Concentrated Value, L.P. report in Form D filings?

The latest linked filings report $635.5M sold across 8 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was AFR Concentrated Value, L.P.'s most recent SEC filing?

AFR Concentrated Value, L.P.'s most recent Form D filing was on 2026-08-04.

How many investors does AFR Concentrated Value, L.P. have?

The most recent Form D filing lists 39 investor(s).

AFR Concentrated Value, L.P.

CIK: 0001616074·Pooled Investment Fund·CAMBRIDGE, MA·Limited Partnership

Reported Sold

$635,476,918

Total Filings

Identified Offerings

Last Filed

Aug 4, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Aug 4, 2026Form D — New notice

Reported sold: $112,736,087 · Target: Indefinite

Section 3(c)·39 investors·Section 3(c)(1)

Aug 7, 2025Form D — New notice

Reported sold: $112,336,087 · Target: Indefinite

Section 3(c)·40 investors·Section 3(c)(1)

Aug 8, 2024Form D — New notice

Reported sold: $111,586,087 · Target: Indefinite

Section 3(c)·41 investors·Section 3(c)(1)

Aug 4, 2023Form D — New notice

Reported sold: $108,907,345 · Target: Indefinite

Section 3(c)·45 investors·Section 3(c)(1)

Aug 4, 2022Form D — New notice

Reported sold: $106,807,345 · Target: Indefinite

Section 3(c)·44 investors·Section 3(c)(1)

Oct 29, 2021Form D/A — Amendment

Reported sold: $48,140,992 · Target: Indefinite

Rule 506(b)·30 investors·Section 3(c), Section 3(c)(1)

Changed: Exemptions

Aug 6, 2021Form D — New notice

Reported sold: $48,140,992 · Target: Indefinite

Section 3(c)·30 investors·Section 3(c)(1)

Aug 6, 2020Form D — New notice

Reported sold: $32,626,960 · Target: Indefinite

Section 3(c)·23 investors·Section 3(c)(1)

Aug 6, 2019Form D/A — Amendment

Reported sold: $2,336,015 · Target: Indefinite

Section 3(c)·6 investors·Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 1, 2018Form D/A — Amendment

Reported sold: $1,760,015 · Target: Indefinite

Section 3(c)·5 investors·Section 3(c)(1)

Changed: Reported amount sold

Aug 2, 2017Form D/A — Amendment

Reported sold: $1,700,000 · Target: Indefinite

Section 3(c)·5 investors·Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 29, 2016Form D/A — Amendment

Reported sold: $1,435,000 · Target: Indefinite

Section 3(c)·4 investors·Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 6, 2015Form D/A — Amendment

Reported sold: $685,000 · Target: Indefinite

Section 3(c)·2 investors·Section 3(c)(1)

Changed: Reported amount sold

Aug 7, 2014Form D — New notice

Reported sold: $180,000 · Target: Indefinite

Section 3(c)·2 investors·Section 3(c)(1)

Fundraising Profile

Exemptions

Section 3(c)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

43%

Latest reported sold across 8 identified offerings

$635,476,918

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

LLC AFR CV GP,

Related Person

Appears on 13 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 4, 2026	New	Indefinite	$112,736,087	39
Aug 7, 2025	New	Indefinite	$112,336,087	40
Aug 8, 2024	New	Indefinite	$111,586,087	41
Aug 4, 2023	New	Indefinite	$108,907,345	45
Aug 4, 2022	New	Indefinite	$106,807,345	44
Oct 29, 2021	Amendment	Indefinite	$48,140,992	30
Aug 6, 2021	New	Indefinite	$48,140,992	30
Aug 6, 2020	New	Indefinite	$32,626,960	23
Aug 6, 2019	Amendment	Indefinite	$2,336,015	6
Aug 1, 2018	Amendment	Indefinite	$1,760,015	5
Aug 2, 2017	Amendment	Indefinite	$1,700,000	5
Jul 29, 2016	Amendment	Indefinite	$1,435,000	4
Aug 6, 2015	Amendment	Indefinite	$685,000	2
Aug 7, 2014	New	Indefinite	$180,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026